Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1.

Clinical Infectious Diseases - Tập 64 Số 1 - Trang 87-91 - 2017
Per Ljungman1,2, Michael Boeckh3,4, Hans H. Hirsch5, Filip Josephson6, Jens Lundgren7, Garrett Nichols8, Andreas Pikis9, Raymund R. Razonable10, Veronica Miller11, Paul Griffiths12
1Departments of Allogeneic Stem Cell Transplantations and Hematology, Karolinska University Hospital, Solna
2Division of Hematology, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm
3Department of Medicine, University of Washington, Seattle
4Vaccine and Infectious Disease and Clinical Research Division, Fred Hutchinson Cancer Research Center
5Department of Biomedicine, University of Basel, Switzerland
6Swedish Medical Products Agency, Uppsala, Sweden
7Centre for Health and Infectious Disease Research (CHIP), Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Denmark
8Chimerix, Inc, Durham, North Carolina
9Division of Antiviral Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland
10Division of Infectious Diseases, Department of Medicine, William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, Minnesota
11Forum for Collaborative HIV Research, University of California, Berkeley
12Institute for Immunity and Transplantation, University College London Medical School, United Kingdom

Tóm tắt

Từ khóa


Tài liệu tham khảo

Ljungman P , Griffiths P . Definitions of cytomegalovirus infection and disease. In: Multidisciplinary approach to understanding cytomegalovirus disease. Paris, Amsterdam : Excerpta Medica International Congress Series, 1993:233–40.

Ljungman, 1996, Cytomegalovirus infections in transplant patients, Scand J Infect Dis, 100, 59

10.1086/339329

10.1038/clpt.2009.140

10.1038/clpt.2014.113

Fryer J , Heath A , Anderson R et al . Expert Committee on Biological Standardization: collaborative study to evaluate the proposed 1st WHO International Standard for human cytomegalovirus (HCMV) for nucleic acid amplification (NAT)-based assays. WHO/BS/102138 2010. Geneva, Switzerland: World Health Organization.

10.1056/NEJM199104113241501

10.1056/NEJMoa1309533

10.1056/NEJMoa1303688

10.1016/S0140-6736(11)60136-0

10.1016/S1473-3099(11)70344-9

10.1016/S1473-3099(11)70024-X

10.1111/j.1600-6143.2010.03074.x

10.1128/JCM.01495-15

10.1093/cid/ciw370

Thông tin
Thông tin xuất bản

Clinical Infectious Diseases

Tập 64 Số 1

87-91

Thông tin tác giả